|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 24.79 EUR | +0.85% |
|
+2.74% | +6.67% |
| Feb. 04 | PHILIPS NV : Buy rating from Barclays | ZD |
| Feb. 03 | Preciseonco research consortium awarded EUR 14.9 million grant in precision cancer treatment | RE |
Chart: Technical Analysis
Technical analysis trends
| Short Term | Mid-Term | Long Term | |
|---|---|---|---|
| Trend | Neutral | Neutral | Bullish |
| Resistance | 26.08 | 26.08 | 25.64 |
| Spread/Res. | -4.95% | -4.95% | -3.32% |
| Spread/Supp. | +10.87% | +10.87% | +9.01% |
| Support | 22.36 | 22.36 | 22.74 |
MarketScreener's Technical Analysis Ratings
| Short Term Timing | |
|---|---|
| Middle Term Timing | |
| Long Term Timing | |
| RSI | |
| Bollinger Spread | |
| Unusual Volumes |
- Stock Market
- Equities
- PHIA Stock
- Charts Philips NV
Select your edition
All financial news and data tailored to specific country editions
